Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves lisdexamfetamine dimesylate (generic) from Mylan as an Original Application; the generic is approved for the same indications a…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (SpecGx LLC)
FDA approved lisdexamfetamine dimesylate under an Original Application (generic) filed by SpecGx LLC.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Alvogen Inc.)
FDA approved the original ANDA for lisdexamfetamine dimesylate (generic) from Alvogen, enabling a generic version of the ADHD and binge eati…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's original ANDA for lisdexamfetamine dimesylate, establishing a generic version of the prodrug used to treat ADHD and …
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Rhodes Pharmaceuticals)
FDA approved an original generic application for lisdexamfetamine dimesylate from Rhodes Pharmaceuticals for the treatment of ADHD and binge…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Lannett Company, Inc.)
FDA approves the original application for lisdexamfetamine dimesylate as a generic drug by Lannett Company, enabling generic supply with the…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA lists Camber Pharmaceuticals' lisdexamfetamine dimesylate as an approved original application (generic) product. The approval covers the…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals LLC's original application for lisdexamfetamine dimesylate as a generic drug. This approval provides a g…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Apotex Corp.)
FDA approves Apotex Corp.'s lisdexamfetamine dimesylate as a generic version of the ADHD and binge eating disorder medication.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic lisdexamfetamine dimesylate product under an Original ANDA for the treatment of ADHD and binge-eating disorder.
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Solco Healthcare US,LLC)
FDA approved Solco Healthcare US, LLC's lisdexamfetamine dimesylate capsules as an original generic application (ANDA) for ADHD and binge ea…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's lisdexamfetamine dimesylate as an original generic application, confirming a generic version of the stimul…
-
FDA approval · 2023-08-25FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approves lisdexamfetamine dimesylate as an Original Application (ANDA) for Teva Pharmaceuticals, providing a generic option for the ADHD…
-
FDA approval · 2023-08-24FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental ANDA from Golden State Medical Supply, Inc. to manufacture a generic combination of dextroamphetamine saccharate…
-
FDA approval · 2023-07-24FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for dexmethylphenidate hydrochloride from Sun Pharmaceutical Industries, indicating a modification/ …
-
FDA approval · 2023-07-20FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Nivagen Pharmaceuticals, Inc., relating to an approved gen…
-
FDA approval · 2023-07-12FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved the supplemental application for methylphenidate hydrochloride from Actavis Pharma, Inc., resulting in an approved supplemental…
-
FDA approval · 2023-07-10FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Xiamen LP Pharmaceutical Co., Ltd.)
FDA approved a supplemental ANDA for clonidine hydrochloride from Xiamen LP Pharmaceutical Co., Ltd., granting approval for a generic clonid…
-
FDA approval · 2023-06-23FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approval of a supplemental application for a methylphenidate hydrochloride product from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2023-06-22FDA Approved: AMPHETAMINE — Original Application (Teva Pharmaceuticals, Inc.)
FDA approved Teva's original application for generic Amphetamine, enabling marketing of amphetamine as a stimulant for ADHD and narcolepsy.
-
FDA approval · 2023-05-08FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC)
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from KVK-TECH, INC., related to an existing generic product.
-
FDA approval · 2023-05-08FDA Approved: ATOMOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals’ supplemental application for atomoxetine, enabling a generic product. Atomoxetine is used to treat …
-
FDA approval · 2023-04-19FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for methylphenidate hydrochloride (LA), expanding access to this extended-release ADHD medicatio…
-
FDA approval · 2023-04-07FDA Approved: ATOMOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for atomoxetine by Teva Pharmaceuticals USA, Inc., indicating an updated labeling for the generic pr…
-
FDA approval · 2023-03-07FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's generic amphetamine salt product, adding four amphetamine salt components (dextroamphetam…